Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Foreign Countries | 2 |
| Pharmaceutical Education | 2 |
| Pharmacy | 2 |
| COVID-19 | 1 |
| Comparative Analysis | 1 |
| Costs | 1 |
| Courses | 1 |
| Curriculum Development | 1 |
| Drug Therapy | 1 |
| Higher Education | 1 |
| Instructional Improvement | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
| Higher Education | 1 |
| Postsecondary Education | 1 |
Audience
Location
| Egypt | 2 |
| Bangladesh | 1 |
| Brazil | 1 |
| China | 1 |
| France | 1 |
| Ghana | 1 |
| India | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Saudi Arabia | 1 |
| South Africa | 1 |
| More ▼ | |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Download full textCristina Vilaplana Prieto – European Journal of Education (EJED), 2021
As the Sars-CoV2 pandemic continues to grow, researchers around the world are urgently seeking new treatments to prevent infection, cure those infected, or lessen the severity of the disease. Although there are several recently approved vaccines, clinical trials are underway to "re-use" drugs normally indicated for other diseases. This…
Descriptors: COVID-19, Pandemics, Pharmacy, Drug Therapy
Peer reviewedAl-Sowaygh, Ibrahim A.; And Others – American Journal of Pharmaceutical Education, 1977
The curriculum of the Riyadh College of Pharmacy was compared with the pharmacy curricula of selected universities in the U. S., England, Egypt, and Ghana. A new curriculum based on the findings is described. (LBH)
Descriptors: Comparative Analysis, Courses, Curriculum Development, Foreign Countries
